Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases

Non-small cell lung cancer (NSCLC) continues to be one of the major causes of cancer-related deaths worldwide, and brain metastases are the major cause of death in NSCLC patients. With recent advances in understanding the underlying molecular mechanism of NSCLC development and progression, mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Ling-Ling, Wang, Lin-Lin, Xing, Li-Gang, Yu, Jin-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2017
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747498/
https://www.ncbi.nlm.nih.gov/pubmed/29354805
http://dx.doi.org/10.1016/j.cdtm.2017.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747498/
https://www.ncbi.nlm.nih.gov/pubmed/29354805
http://dx.doi.org/10.1016/j.cdtm.2017.11.001

Ejemplares similares